-
Featured Column
Deciphering the Puzzle of Dementia
By John Halamka and Paul Cerrato — A diagnosis of dementia often disrupts the lives of patients and their families. AI-enabled algorithms can provide a more definitive diagnosis, and in some cases help detect curable forms of the condition.
By John Halamka and Paul Cerrato — Developing and implementing AI-driven algorithms in health care has proven far more complicated than we first imagined. The new Coalition for Health AI (CHAI) guidelines provide the much-needed blueprint.
By John Halamka and Paul Cerrato — Shared decision-making doesn't mean encouraging patients to take the path of least resistance. Prescribing lifestyle changes may not put a smile on their faces, but the long-term benefits often outweigh the risks of lifelong dependence on prescription medication.
By John Halamka and Paul Cerrato — New digital tools are a two-edged sword that come with a unique set of benefits and risks. We need a regulatory framework to manage them responsibly.
By John Halamka and Paul Cerrato — With over 10,000 mental health apps available, it’s difficult to know which ones will actually have a therapeutic impact. Fortunately, enough high-quality evidence is available to help clinicians and patients make an informed choice.
By John Halamka and Paul Cerrato — The bionic man and woman are no longer fictional TV characters. With the help of state-of-the-art digital technology, they’re your next-door neighbor.
By John Halamka and Paul Cerrato — The National Institute of Standards and Technology recently published a framework that will help health care providers assess AI trustworthiness, explainability, and bias.
By John Halamka and Paul Cerrato — ChatGPT and similar systems will increasingly be part of our lives, including health care. We need guidelines to ensure their ethical deployment.
By John Halamka and Paul Cerrato — When clinicians have no definitive guidelines or empirical evidence on which to base their decisions, they still must come up with a care plan that meets their patients’ needs. Combining data from the available published studies with intelligence gleaned from electronic patient records can often address the dilemma.
By John Halamka and Paul Cerrato - The broad access to such services that occurred at the beginning of the COVID-19 pandemic should not be rolled back. Finding a way to extend the regulatory waivers that made this possible is in our patients’ best interest.